Labopharm submits FDA application for side-effect-reducing antidepressant

MONTREAL - Labopharm Inc. has submitted a new drug application to the U.S. Food and Drug Administration for its once-daily formulation of antidepressant trazodone which studies indicate reduces side-effects....More